Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid

MLA

Camilla Vassallo, et al. “Omalizumab as a Corticosteroid-Sparing Agent in the Treatment of Bullous Pemphigoid.” Dermatologic TherapyREFERENCES, vol. 35, no. 12, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6dbfd6c7521c23ee52fcc4358e154679&authtype=sso&custid=ns315887.

APA

Camilla Vassallo, Anita Somenzi, Mara De Amici, Stefania Barruscotti, & Valeria Brazzelli. (2022). Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid. Dermatologic TherapyREFERENCES, 35(12).

Chicago

Camilla Vassallo, Anita Somenzi, Mara De Amici, Stefania Barruscotti, and Valeria Brazzelli. 2022. “Omalizumab as a Corticosteroid-Sparing Agent in the Treatment of Bullous Pemphigoid.” Dermatologic TherapyREFERENCES 35 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6dbfd6c7521c23ee52fcc4358e154679&authtype=sso&custid=ns315887.